A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer.
Juarez TM, Gill JM, Heng A, Carrillo JA, Wagle N, Nomura N, Nguyen M, Truong J, Dobrawa L, Sivakumar W, Barkhoudarian G, Kelly DF, Kesari S.
Juarez TM, et al. Among authors: gill jm.
Neurooncol Adv. 2024 Mar 30;6(1):vdae049. doi: 10.1093/noajnl/vdae049. eCollection 2024 Jan-Dec.
Neurooncol Adv. 2024.
PMID: 38680990
Free PMC article.